A Triple Therapeutic Regiment Consisted of Colchicine, Thalidomide and Total Glucosides of Paeony Is Effective and Well‐Tolerated for Treating Mucocutaneous Involvement in Patients With Behcet's Disease

Documenti analoghi

• Unraveling the Clinical and Molecular Landscape of Myocardial Infarction in Behçet's Syndrome: A Comprehensive Analysis
  di: Li‐Yang Zhang, et al.
  Pubblicazione: (2025)
• Coexistence of ankylosing spondylitis and Behçet's disease: Successful treatment with upadacitinib
  di: Krasimir Kraev, et al.
  Pubblicazione: (2024)
• RUNX1 Is an Independent Prognostic Marker Involved in Immune Infiltration and Therapeutic Responses in Clear Cell Renal Cell Carcinoma Patients Through Cluster Regulation With RUNX2
  di: Jingang Jian, et al.
  Pubblicazione: (2025)
• A20 as a Potential Therapeutic Target for COVID‐19
  di: Yongyao Wu, et al.
  Pubblicazione: (2025)
• Alleviating effect of Nexrutine on mucosal inflammation in mice with ulcerative colitis: Involvement of the RELA suppression
  di: Hongyun Xu, et al.
  Pubblicazione: (2024)